Headlines
-
Unregulated CMs pose risk
Monday | Feb 6 2017SIGNIFICANT risks are associated with some traditional herbal products in widespread use in Australia, according to the authors of an article in the latest edition of the Medical Journal of Australia.
-
Compounding alive & well
Friday | Feb 3 2017THE art and science of compounding medicines is alive and well in Australia, according to a new article in the latest issue of Australian Prescriber.
-
Turnbull prevention push
Friday | Feb 3 2017COMPLEMENTARY medicines Australia (CMA) said it has been "heartened" by Prime Minister Malcolm Turnbull's comment made at the National Press Club this week that the Australian Government would implement "in 2017, a new focus on preventive health.
-
QCPP set for makeover
Friday | Feb 3 2017THE Quality Care Pharmacy Program will undergo significant changes later this year, with an "improved" scheme to debut effective from 01 Jul.
-
‘Must attend’ 2017 event
Thursday | Feb 2 2017THE Pharmaceutical Society of Australia (PSA) has announced that more than 50 international and local presenters will discuss major pharmacy issues at PSA17, its flagship annual conference set for 28-30 Jul.
-
WA funds real-time ERRCD
Thursday | Feb 2 2017WESTERN Australia Health has announced it will overhaul the state's current pharmaceutical prescription monitoring system, with $1m allocated for the purpose.
-
NZ pharmacist-GP pact
Wednesday | Feb 1 2017PHARMACISTS and doctors in New Zealand have together developed a new "person-centred framework," which would see both professions work together to deliver an integrated model of health care.
-
Student entrepreneur comp
Tuesday | Jan 31 2017THE Pharmacy Guild of Australia has announced the commencement of the 2017 eleventh National Student Business Plan Competition, designed to test "the flair and entrepreneurship of students preparing for a career in community pharmacy".
-
Ulipristal S3 from tomorrow
Tuesday | Jan 31 2017PHARMACISTS will continue to play a critical role in emergency contraception from 01 Feb 2017, when the ulipristal acetate pill will become available as a Schedule 3 (Pharmacist Only) medicine.
-
FDA warns on Hylands
Monday | Jan 30 2017THE US Food and Drug Administration (FDA) has heightened its warning level about homeopathic teething products (PD 04 Oct), formally advising that tablets containing belladonna pose an unnecessary risk to infants.